Prevention of Bortezomib-Induced Peripheral Neuropathy in Newly Multiple Myeloma Patients Using Nervonic Acid, Curcuma Rizoma, and L-Arginine Compound: A Pilot Study

INTRODUCTION: This is a phase II pilot study to evaluate the efficacy of a nutraceutical compound composed of nervonic acid, curcuma rizoma, and l-Arginine to prevent the onset of bortezomib-induced peripheral neuropathy (BIPN) in 16 newly diagnosed multiple myeloma (MM) patients treated with bortez...

Descripción completa

Detalles Bibliográficos
Autores principales: Maschio, Marta, Maialetti, Andrea, Marchesi, Francesco, Gumenyuk, Svitlana, Pisani, Francesco, Papa, Elena, Galiè, Edvina, Koudriavtseva, Tatiana, Graziano, Giuliana, Giannarelli, Diana, Mengarelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403460/
https://www.ncbi.nlm.nih.gov/pubmed/35866451
http://dx.doi.org/10.1177/15347354221114142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403460/
https://www.ncbi.nlm.nih.gov/pubmed/35866451
http://dx.doi.org/10.1177/15347354221114142

Ejemplares similares